Cargando…

Modulation of MDR1 and MRP3 Gene Expression in Lung Cancer Cells after Paclitaxel and Carboplatin Exposure

Carboplatin-paclitaxel is a reference regimen in the treatment of locally advanced or disseminated non-small cell lung cancer (NSCLC). This paper discusses the multidrug resistance developed with this drug combination, which is one of the major obstacles to successful treatment. In order to understa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Melguizo, Consolación, Prados, Jose, Luque, Raquel, Ortiz, Raúl, Caba, Octavio, Álvarez, Pablo J., Gonzalez, Beatriz, Aranega, Antonia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546711/ https://www.ncbi.nlm.nih.gov/pubmed/23443122 http://dx.doi.org/10.3390/ijms131216624

Ejemplares similares

5-Fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer
por: Ortiz, Raúl, et al.
Publicado: (2012)

Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression
por: Perazzoli, Gloria, et al.
Publicado: (2015)

Multidrug Resistance Phenotype in the RMS‐GR Human Rhabdomyosarcoma Cell Line Obtained after Polychemotherapy
por: Prados, Jose, et al.
Publicado: (1999)

gef Gene Expression in MCF-7 Breast Cancer Cells is Associated with a Better Prognosis and Induction of Apoptosis by p53-Mediated Signaling Pathway
por: Boulaiz, Houria, et al.
Publicado: (2011)

MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
por: Melguizo, Consolación, et al.
Publicado: (2012)

Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(butylcyanoacrylate) nanoparticles
por: Melguizo, Consolación, et al.
Publicado: (2015)

Proteomic biomarkers in body fluids associated with pancreatic cancer
por: Jimenez-Luna, Cristina, et al.
Publicado: (2018)

Characterization of a New Human Embryonal Rhabdomyosarcoma Cell Line, RMS‐GR
por: Fernández, Juan Emilio, et al.
Publicado: (1998)

Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications
por: Ortiz, Raúl, et al.
Publicado: (2021)

Nanomedicine: Application Areas and Development Prospects
por: Boulaiz, Houria, et al.
Publicado: (2011)

Modulation of Myogenic Differentiation in a Human Rhabdomyosarcoma Cell Line by a New Derivative of 5‐Fluorouracil (QF‐3602)
por: Marchal, Juan Antonio, et al.
Publicado: (2000)

Circulating PTGS2, JAG1, GUCY2C and PGF mRNA in Peripheral Blood and Serum as Potential Biomarkers for Patients with Metastatic Colon Cancer
por: Jimenez-Luna, Cristina, et al.
Publicado: (2021)

Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
por: Oliver, Jaime Antonio, et al.
Publicado: (2014)

Cytotoxicity and reversal effect of sertraline, fluoxetine, and citalopram on MRP1- and MRP7-mediated MDR
por: Bin Kanner, Yuval, et al.
Publicado: (2023)

Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticles
por: Cabeza, Laura, et al.
Publicado: (2015)

Tripalmitin nanoparticle formulations significantly enhance paclitaxel antitumor activity against breast and lung cancer cells in vitro
por: Leiva, María Carmen, et al.
Publicado: (2017)

Evaluation of poly (lactic-co-glycolic acid) nanoparticles to improve the therapeutic efficacy of paclitaxel in breast cancer
por: Cabeza, Laura, et al.
Publicado: (2022)

Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells
por: Farace, Cristiano, et al.
Publicado: (2015)

Biomimetic Magnetoliposomes as Oxaliplatin Nanocarriers: In Vitro Study for Potential Application in Colon Cancer
por: Garcia-Pinel, Beatriz, et al.
Publicado: (2020)

Nanomedicine to Overcome Multidrug Resistance Mechanisms in Colon and Pancreatic Cancer: Recent Progress
por: Ortíz, Raúl, et al.
Publicado: (2021)

Meroxest improves the prognosis of immunocompetent C57BL/6 mice with allografts of E0771 mouse breast tumor cells
por: Carrasco, Esther, et al.
Publicado: (2016)

Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review
por: Gago, Lidia, et al.
Publicado: (2023)

Oxaliplatin–Biomimetic Magnetic Nanoparticle Assemblies for Colon Cancer-Targeted Chemotherapy: An In Vitro Study
por: Jabalera, Ylenia, et al.
Publicado: (2019)

Comparison of paclitaxel liposomes combined with carboplatin versus paclitaxel combined with carboplatin in the treatment of advanced ovarian cancer
por: Tan, Xiangbin, et al.
Publicado: (2023)

Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics
por: Martín-Blázquez, Ariadna, et al.
Publicado: (2020)

Prognostic Value of RT-PCR Tyrosinase Detection in Peripheral Blood of Melanoma Patients
por: Carrillo, Esmeralda, et al.
Publicado: (2006)

The Antitumor Activity of Sodium Selenite Alone and in Combination with Gemcitabine in Pancreatic Cancer: An In Vitro and In Vivo Study
por: Doello, Kevin, et al.
Publicado: (2021)

MRP1 but Not MDR1 Is Associated with Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
por: Taheri, Mohsen, et al.
Publicado: (2013)

MDR-1 and MRP-1 activity in peripheral blood leukocytes of rheumatoid arthritis patients
por: Micsik, Tamás, et al.
Publicado: (2015)

Cancer Stem Cells in Sarcomas: In Vitro Isolation and Role as Prognostic Markers: A Systematic Review
por: Chico, Maria Angeles, et al.
Publicado: (2023)

Ischemic Colitis Associated with Paclitaxel and Carboplatin Combination
por: Elsayed, Ahmed Gamal, et al.
Publicado: (2017)

Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer
por: Martín-Blázquez, Ariadna, et al.
Publicado: (2019)

In Vitro Efficacy of Extracts and Isolated Bioactive Compounds from Ascomycota Fungi in the Treatment of Colorectal Cancer: A Systematic Review
por: Luque, Cristina, et al.
Publicado: (2022)

Antibody-Functionalized Nanoformulations for Targeted Therapy of Colorectal Cancer: A Systematic Review
por: Cepero, Ana, et al.
Publicado: (2022)

Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport
por: Evers, R, et al.
Publicado: (2000)

Localization of the ATP-binding cassette (ABC) transport proteins PfMRP1, PfMRP2, and PfMDR5 at the Plasmodium falciparum plasma membrane
por: Kavishe, Reginald A, et al.
Publicado: (2009)

Comparison of Neoadjuvant Chemotherapy Efficiency in Advanced Ovarian Cancer Patients Treated With Paclitaxel Plus Carboplatin and Intraperitoneal Bevacizumab vs. Paclitaxel With Carboplatin
por: Tao, Yin, et al.
Publicado: (2022)

Bengamide Analogues Show A Potent Antitumor Activity against Colon Cancer Cells: A Preliminary Study
por: García-Pinel, Beatriz, et al.
Publicado: (2020)

Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides
por: Lo, Yu-Li, et al.
Publicado: (2014)

MDR-1 and MRP2 Gene Polymorphisms in Mexican Epileptic Pediatric Patients with Complex Partial Seizures
por: Escalante-Santiago, David, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tgj9eou7u612rq9t2bqtb4j3pb